Trial Profile
Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Ankylosing spondylitis
- Focus Pharmacodynamics
- Acronyms COMARIS
- 15 Jun 2019 Results(n=104) presented at the 20th Annual Congress of the European League Against Rheumatism
- 28 Sep 2015 Status changed from recruiting to completed.
- 14 Aug 2013 New trial record